Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Catalyst Biosciences Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    15.97
    -1.02 (-6.00%)
    At close: Jun 27, 2025, 3:59 PM
    17.08
    6.98%
    After-hours: Jun 27, 2025, 05:22 PM EDT

    Catalyst Biosciences Statistics

    Share Statistics

    Catalyst Biosciences has 86.42M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 86.42M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 1.83M

    Failed to Deliver (FTD) Shares

    n/a
    		 141,195

    FTD / Avg. Volume

    n/a
    		 593.78%

    Short Selling Information

    The latest short interest is 34.05K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 34.05K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 1.52 and the forward PE ratio is null. Catalyst Biosciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 1.52

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.41

    Forward PS

    n/a
    		 9.9

    PB Ratio

    n/a
    		 0.69

    P/FCF Ratio

    n/a
    		 -7.31

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Catalyst Biosciences has an Enterprise Value (EV) of 33.29M.

    EV / Sales

    n/a
    		 0.31

    EV / EBITDA

    n/a
    		 2.06

    EV / EBIT

    n/a
    		 -9.14

    EV / FCF

    n/a
    		 -5.59

    Financial Position

    The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 3.32

    Quick Ratio

    n/a
    		 2.99

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 0.1

    Debt / FCF

    n/a
    		 -0.27

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 45.07% and Return on Invested Capital is 18.64%.

    Return on Equity

    n/a
    		 45.07%

    Return on Assets

    n/a
    		 22.76%

    Return on Invested Capital

    n/a
    		 18.64%

    Revenue Per Employee

    n/a
    		 $15,108,142.86

    Profits Per Employee

    n/a
    		 $4,076,857.14

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0.84

    Inventory Turnover

    n/a
    		 0.61

    Taxes

    Income Tax

    n/a
    		 -5.32M

    Effective Tax Rate

    n/a
    		 -22.91%

    Stock Price Statistics

    The stock price has increased by 3211.17% in the last 52 weeks. The beta is 1.29, so Catalyst Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.29

    52-Week Price Change

    n/a
    		 3211.17%

    50-Day Moving Average

    n/a
    		 3.19

    200-Day Moving Average

    n/a
    		 1.02

    Relative Strength Index (RSI)

    n/a
    		 80.39

    Average Volume (20 Days)

    n/a
    		 23,779

    Income Statement

    In the last 12 months, Catalyst Biosciences had revenue of 105.76M and earned 28.54M in profits. Earnings per share was 0.34.

    Revenue

    n/a
    		 105.76M

    Gross Profit

    n/a
    		 101.87M

    Operating Income

    n/a
    		 16.16M

    Net Income

    n/a
    		 28.54M

    EBITDA

    n/a
    		 16.16M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 0.34
    Full Income Statement

    Balance Sheet

    The company has 11.81M in cash and 1.6M in debt, giving a net cash position of 10.21M.

    Cash & Cash Equivalents

    n/a
    		 11.81M

    Total Debt

    n/a
    		 1.6M

    Net Cash

    n/a
    		 10.21M

    Retained Earnings

    n/a
    		 -73.45M

    Total Assets

    n/a
    		 129.79M

    Working Capital

    n/a
    		 49.46M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -3.64M and capital expenditures -2.31M, giving a free cash flow of -5.96M.

    Operating Cash Flow

    n/a
    		 -3.64M

    Capital Expenditures

    n/a
    		 -2.31M

    Free Cash Flow

    n/a
    		 -5.96M

    FCF Per Share

    n/a
    		 -0.07
    Full Cash Flow Statement

    Margins

    Gross margin is 96.33%, with operating and profit margins of 15.28% and 26.98%.

    Gross Margin

    n/a
    		 96.33%

    Operating Margin

    n/a
    		 15.28%

    Pretax Margin

    n/a
    		 21.95%

    Profit Margin

    n/a
    		 26.98%

    EBITDA Margin

    n/a
    		 15.28%

    EBIT Margin

    n/a
    		 15.28%

    FCF Margin

    n/a
    		 -5.63%

    Dividends & Yields

    CBIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 65.59%

    FCF Yield

    n/a
    		 -13.69%
    Dividend Details

    Analyst Forecast

    The average price target for CBIO is $25, which is 47.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $25

    Price Target Difference

    n/a
    		 47.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 2.37

    Graham Upside

    n/a
    		 -86%

    Stock Splits

    The last stock split was on Jun 16, 2025. It was a backward split with a ratio of 1:100.

    Last Split Date

    n/a
    		 Jun 16, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:100

    Scores

    Altman Z-Score

    n/a
    		 2.46

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist